Linked Life Data

2639638

Source:http://linkedlifedata.com/resource/pubmed/id/2639638

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3-4
pubmed:dateCreated
1990-8-14
pubmed:abstractText
This study is a continuation of our previous work demonstrating the potentiating activity of TFX on cyclophosphamide-induced immunosuppression. Mice primed with TFX subsequently received cyclophosphamide and antigen and their B cell responses were evaluated with an aid of antigen-specific and reverse plaque forming cell assay. Cyclophosphamide-dependent inhibition of immunoglobulin synthesis was significantly stronger in mice pretreated with TFX than in controls. However, the synergistic immunosuppressive action of TFX with cyclophosphamide was evident only when polyclonal but not specific humoral response was studied.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0004-069X
pubmed:author
pubmed:issnType
Print
pubmed:volume
37
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
415-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
TFX modulates the immunosuppressive effect of cyclophosphamide on antibody production in mice.
pubmed:affiliation
Department of Experimental Immunosuppression, Medical Academy, Warsaw.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't